Colchicine in coronary disease: Using the available to enable the sustainable

ATL Fiolet

Research output: ThesisDoctoral thesis 1 (Research UU / Graduation UU)

13 Downloads (Pure)

Abstract

The general aim of this thesis is to investigate wheter anti-inflammatory therapy improves outcomes in patients with coronary disease, based on a methodology that combines sustainable collection of evidence with the highest level of fidelity.
This aim is accomplished using two main approaches. The first approach is clinically and mechanistically orientated and described in parts I, II, and III of this thesis. In these parts, we present the rationale and methods for repurposing a well-known drug, colchicine, to modulate crucial, but to date unaddressed, biological pathways in atherosclerosis. The second approach is methodologically orientated and described in parts II and IV of this thesis. In these parts, we show that investigator-initiated research can be undertaken with scientifically sound methods, by using a pragmatic trial design and innovative data collection methods.
Original languageEnglish
Awarding Institution
  • University Medical Center (UMC) Utrecht
Supervisors/Advisors
  • Grobbee, Rick, Primary supervisor
  • Doevendans, Pieter, Supervisor
  • Cornel, Jan H., Supervisor
  • Mosterd, A, Co-supervisor
Award date24 Feb 2022
Publisher
Print ISBNs978-94-93108-30-1
DOIs
Publication statusPublished - 24 Feb 2022

Keywords

  • Cardiology
  • Coronary artery disease
  • Atherosclerosis
  • Colchicine
  • Drug rediscovery
  • Clinical trials
  • Placebo controlled
  • Inflammation

Fingerprint

Dive into the research topics of 'Colchicine in coronary disease: Using the available to enable the sustainable'. Together they form a unique fingerprint.

Cite this